Tuning lipid nanoparticle pKa to exploit the vitronectin corona for tumor-selective mRNA delivery to the lung

MOLECULAR THERAPY NUCLEIC ACIDS · Published 2026-08-01 · DOI 10.1016/j.omtn.2026.103020

Free full text

Authors (3)

Yoon Tae Goo, Olena R. Taratula, Oleh Taratula

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Citation

Goo, Y., Taratula, O., Taratula, O. (2026). Tuning lipid nanoparticle pKa to exploit the vitronectin corona for tumor-selective mRNA delivery to the lung. MOLECULAR THERAPY NUCLEIC ACIDS. https://doi.org/10.1016/j.omtn.2026.103020

Related articles

• Decoding preeclampsia: A fusion of multi-view machine learning and multi-omics to identify putative inflammation-related mechanisms · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Y-RNAs and their fragments reflect kidney injury in diabetic kidney disease · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Quieting the carrier: Matching delivery to immunology in anti-inflammatory mRNA therapy · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Polyamines are i-Motif disruptors · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Codon-Optimized Npc1 mRNA corrects Niemann-Pick type C1 disease phenotypes in vitro and in vivo · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Neonatal expression of human FMRP isoform corrects cortical deficits and improves behavior in a mouse model of fragile X syndrome · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Intranasal Tat-modified PEG-PCL nanomicelles delivering anti-RelA siRNA attenuate ischemia-reperfusion injury in transient MCAO mice · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Antisense Peptide Nucleic Acids Targeting Ribosomal Protein Genes: A Novel Strategy Against Carbapenem-resistant Acinetobacter baumannii · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• To scramble or not: steric blocking 2′-MOE/PS control antisense oligonucleotides across cellular models · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• ADAR RNA editing for cardiovascular disease: Targeting B4GALT1 to modulate lipid metabolism through reduced galactosyltransferase activity · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal